Market News / Story
AngioDynamics 2026: Revenue $80.92M, EPS ($0.17) — 10-Q Summary
·
AngioDynamics reported results for the quarter ended 2026 with revenue rising to $80.92M and a reduced loss per share versus the prior-year quarter, as improved gross margins and product demand helped narrow the net loss. Financial Highlights MetricCurrent quarterPrior year quarterYoY changeRevenue¹$80.92M$75.71M6.9%Net income²($7.1M)($10.9M)34.9%Diluted EPS³($0.17)($0.26)34.6% ¹ Reported as “Net sales”. ² Reported as “Net loss”. ³ Reported as “Diluted loss per share”.…